MARC Record from marc_columbia

LEADER: 05945cam a2200685 a 4500
001 15096788
005 20221112231335.0
006 m o d
007 cr cnu---unuuu
008 140125s2014 nju ob 000 0 eng d
035 $a(OCoLC)ocn869090933
035 $a(NNC)15096788
040 $aEBLCP$beng$epn$cEBLCP$dOCLCQ$dOHS$dIDEBK$dE7B$dYDXCP$dCUS$dSTF$dN$T$dOCLCF$dCRCPR$dOCLCQ$dCOO$dOCLCQ$dUAB$dCAUOI$dOCLCQ$dU3W$dNLE$dOCLCO$dAU@$dOCLCO$dUKMGB$dOCLCO$dOCLCA$dYDX$dTYFRS$dLEAUB$dOCLCQ$dK6U$dOCLCO$dOCLCQ
015 $aGBB7A0300$2bnb
016 7 $a018370963$2Uk
020 $a9789814463157$q(electronic bk.)
020 $a9814463159$q(electronic bk.)
020 $a9814463140
020 $a9789814463140
020 $z9789814463140
035 $a(OCoLC)869090933
037 $aTANDF_338243$bIngram Content Group
050 4 $aRM262$b.C44 2014
060 4 $aQV 744
072 7 $aMED$x071000$2bisacsh
082 04 $a615.19$223
049 $aZCUA
245 00 $aChemotherapeutic engineering :$bcollected papers of Si-Shen Feng - a tribute to Shu Chien on his 82nd birthday /$cedited by Si-Shen Feng, Jenny Rompas, Stanford Chong.
260 $aHoboken :$bPan Stanford,$c2014.
300 $a1 online resource (1025 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
505 0 $aFront Cover; Contents; Preface; Part I -- Introduction; Chapter 1 -- Chemotherapeutic Engineering: Concept, Feasibility, Safety and Prospect-A Tribute to Shu Chien on His 82nd Birthday; Part II -- Chemotherapeutic Engineering: Concepts; Chapter 2 -- Chemotherapeutic Engineering: Application and Further Development of Chemical Engineering Principles for Chemotherapy of Cancer and Other Diseases; Chapter 3 -- New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?; Chapter 4 -- Nanoparticles of Biodegradable Polymers for New-Concept Chemotherapy.
505 8 $aChapter 5 -- Nanoparticles of Biodegradable Polymers for Cancer TreatmentPart III -- Chemotherapeutic Engineering: Feasibility; Chapter 6 -- Chemotherapeutic Engineering: Vitamin E TPGS-Emulsified Nanoparticles of Biodegradable Polymers Realized Sustainable Paclitaxel Chemotherapy for 168 h in vivo; Part IV -- Chemotherapeutic Engineering: Further Proof-of Concept Experimental Results; Chapter 7 -- In vitro and in vivo Investigation on PLA-TPGS Nanoparticles for Controlled and Sustained Small Molecule Chemotherapy.
505 8 $aChapter 8 -- In vitro and in vivo Evaluation of Methoxy Polyethylene Glycol-Polylactide (MPEG-PLA) Nanoparticles for Small-Molecule Drug ChemotherapyChapter 9 -- The Drug Encapsulation Efficiency, in vitro Drug Release, Cellular Uptake and Cytotoxicity of Paclitaxel-Loaded Poly(Lactide)-Tocopheryl Polyethylene Glycol Succinate Nanoparticles; Chapter 10 -- Nanoparticles of Poly(D, L-Lactide)/Methoxy Poly(Ethylene Glycol)-Poly(D, L-Lactide) Blends for Controlled Release of Paclitaxel.
505 8 $aChapter 11 -- In vitro and in vivo Studies on Vitamin ETPGS-Emulsified Poly(D, L-Lactic-co-Glycolic Acid) Nanoparticles for Paclitaxel FormulationChapter 12 -- Nanoparticles of Poly(Lactide)/Vitamin E TPGS Copolymer for Cancer Chemotherapy: Synthesis, Formulation, Characterization and in vitro Drug Release; Chapter 13 -- A Novel Controlled Release Formulation for the Anticancer Drug Paclitaxel (Taxol®): PLGA Nanoparticles Containing Vitamin E TPGS.
505 8 $aChapter 14 -- Fabrication, Characterization and in vitro Release of Paclitaxel (Taxol®) Loaded Poly(Lactic-co-Glycolic Acid) Microspheres Prepared by Spray Drying Technique with Lipid/Cholesterol EmulsifiersChapter 15 -- Effects of Emulsifiers on the Controlled Release of Paclitaxel (Taxol®) from Nanospheres of Biodegradable Polymers; Part V -- Chemotherapeutic Engineering: Drug Targeting; Chapter 16 -- Copolymer Technology for Advanced Nanomedicine; Chapter 17 -- A Strategy for Precision Engineering of Nanoparticles of Biodegradable Copolymers for Quantitative Control of Targeted Drug Delivery.
505 8 $aChapter 18 -- Folic Acid Conjugated Nanoparticles of Mixed Lipid Monolayer Shell and Biodegradable Polymer Core for Targeted Delivery of Docetaxel.
520 $aThis book is a collection of the major publications of the authors in the emerging area of chemotherapeutic engineering. It describes and demonstrates the concept, feasibility, safety and prospect of chemotherapeutic engineering through a full spectrum of proof-of-concept experiments from design, characterization, in vitro cellular uptake, cytotoxicity, to in vivo pharmacokinetics, biodistribution, and xenograft tumor model of the various nanocarriers, such as prodrugs, micelles, liposomes, and nanoparticles of biodegradable polymers.
588 0 $aPrint version record.
504 $aIncludes bibliographical references at the end of each chapters.
650 0 $aPharmaceutical chemistry.
650 0 $aAntineoplastic agents.
650 0 $aAntimitotic agents.
650 2 $aNeoplasms$xdrug therapy
650 2 $aChemistry, Pharmaceutical
650 2 $aAntimitotic Agents
650 2 $aAntineoplastic Agents
650 6 $aChimie pharmaceutique.
650 6 $aAnticancéreux.
650 7 $aMEDICAL$xPharmacology.$2bisacsh
650 7 $aAntineoplastic agents.$2fast$0(OCoLC)fst00810595
650 7 $aPharmaceutical chemistry.$2fast$0(OCoLC)fst01060115
700 1 $aFeng, Si-Shen,$eeditor.
700 1 $aChong, Stanford,$eeditor.
700 1 $aRompas, Jenny,$eeditor.
776 08 $iPrint version:$tChemotherapeutic engineering : collected papers of Si-Shen Feng : a tribute to Shu Chien on his 82nd birthday.$d[Place of publication not identified] : Pan Stanford Publishing, ©2014$hxxix, 981 pages$z9789814463140
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio15096788$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS